Ana
Ortega Eslava
Consultora Farmacéutica
Hospital General Universitario Gregorio Marañón
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (9)
2023
-
Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients
Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215
2022
-
Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study
Intensive Care Medicine, Vol. 48, Núm. 7, pp. 850-864
2018
-
Limitation of life support techniques at admission to the intensive care unit: A multicenter prospective cohort study
Journal of Intensive Care, Vol. 6, Núm. 1
2016
-
Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome
Critical Care, Vol. 20, Núm. 1
2011
-
Literature review on the structure and operation of Pharmacy and Therapeutics Committees
International Journal of Clinical Pharmacy, Vol. 33, Núm. 3, pp. 475-483
-
Role of the hospital pharmacy and therapeutics committee in detecting and regulating off-label drug use, reply to letter
International Journal of Clinical Pharmacy
-
Variabilidad en la actividad y los resultados de la evaluación de nuevos medicamentos por las comisiones de farmacia y terapéutica de los hospitales en España
Farmacia Hospitalaria, Vol. 35, Núm. 6, pp. 305-314
2010
-
Structure and procedures of the pharmacy and therapeutic committees in Spanish hospitals
Pharmacy World and Science, Vol. 32, Núm. 6, pp. 767-775
2002
-
Implications of left bundle branch block in acute myocardial infarction treated with primary angioplasty
American Journal of Cardiology, Vol. 90, Núm. 4, pp. 401-403